All content for OncoTalks | Oncology Insights at Your Fingertips is the property of Ontada Learn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Innovative Genomic Profiling in HR+/HER2- Metastatic Breast Cancer
OncoTalks | Oncology Insights at Your Fingertips
10 minutes 44 seconds
5 months ago
Innovative Genomic Profiling in HR+/HER2- Metastatic Breast Cancer
In this episode of OncoTalks, Dr. Mia Levy and Dr. Paul Conkling discuss new FDA-approved treatments and therapies for HR-positive, HER2-negative metastatic breast cancer. Discover innovative genomic testing techniques that are changing the identification of mutations, paving the way for more precise treatment strategies. Tune in as we spotlight advancements in personalized breast cancer care and learn about the advantages of liquid biopsy testing.
